Obinutuzumab
CAT:
804-HY-P9910-03
Size:
10 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
Obinutuzumab
- CAS Number: 949142-50-1
- UNSPSC Description: Obinutuzumab (GA101) a novel glycoengineered Type II CD20 humanized IgG1 monoclonal antibody in development for non-Hodgkin lymphoma.
- Target Antigen: CD20
- Type: Inhibitory Antibodies
- Related Pathways: Immunology/Inflammation
- Applications: Cancer-programmed cell death
- Field of Research: Cancer
- Assay Protocol: https://www.medchemexpress.com/Obinutuzumab.html
- Purity: 99.4
- Solubility: H2O
- Smiles: [Obinutuzumab]
- References & Citations: [1]Herter S, et al. Preclinical activity of the type II CD20 antibody GA101 (obinutuzumab) compared with rituximab and ofatumumab in vitro and in xenograft models. Mol Cancer Ther. 2013 Oct;12(10):2031-42.|[2]Dalle S, et al. Preclinical studies on the mechanism of action and the anti-lymphoma activity of the novel anti-CD20 antibody -GA101. Mol Cancer Ther. 2011 Jan;10(1):178-85.|[3]Herting F, et al. Enhanced anti-tumor activity of the glycoengineered type II CD20 antibody obinutuzumab(GA101) in combination with chemotherapy in xenograft models of human lymphoma. Leuk Lymphoma. 2014 Sep;55(9):2151-5160.
- Shipping Conditions: Blue Ice
- Storage Conditions: Store at 4°C for 2 years, do not freeze
- Clinical Information: Launched